Cepheid Receives FDA Authorization with CLIA Waiver for Xpert® HCV
Go back to Cepheid Receives FDA Authorization with CLIA Waiver for Xpert® HCV| Danaher Corp. (NYSE: DHR) | Delayed: 210.70 +11.12 (5.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $199.58 | 52 Week High | $102.79 | |||
| Open | $203.10 | 52 Week Low | $75.71 | |||
| Day High | $211.95 | P/E | 55.45 | |||
| Day Low | $202.91 | EPS | $3.80 | |||
| Volume | 2,887,167 | |||||
